Find Research Projects

Search results

• A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Single Injection Femoral Nerve Block with Liposome Bupivacaine for Postsurgical Analgesia in Subject

  Lindsey, R.

  Pacira Pharmaceuticals Inc

  1/18/13 → 1/17/15

  Project: Other project

• A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Single Injection Femoral Nerve Block with Liposome Bupivacaine for Postsurgical Analgesia in Subject

  Lindsey, R.

  1/18/13 → 1/17/15

  Project: Other project

• A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3b Studyto Evaluate the Safety and Efficacy of Benrali21Jmab 30 mg sc in Patients with Sewre Asthma Uncontrolled on Standard of care Treatment

  Calhoun, W.

  AstraZeneca LP

  10/12/17 → 10/11/19

  Project: Other project

• A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3b Studyto Evaluate the Safety and Efficacy of Benrali21Jmab 30 mg sc in Patients with Sewre Asthma Uncontrolled on Standard of care Treatment

  Calhoun, W.

  10/12/17 → 10/11/19

  Project: Other project

• A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3b Study to Evaluate the Safety and Efficacy of Benrali21Jmab 30 mg sc in Patients with Sewre Asthma Uncontrolled on Standard of care Treatment

  Calhoun, W.

  10/12/17 → 10/11/19

  Project: Other project

• A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-Controlled,Phase 3 Efficacy and Safety Study of Benralizumab (MEDI-353) to Reduce Oral Corticosteroid Use in Patients with Uncontrolled Asthma on High Dose Inhaled Corticosteroid plus Long-

  Calhoun, W.

  7/15/14 → 12/31/16

  Project: Other project

• A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-Controlled,Phase 3 Efficacy and Safety Study of Benralizumab (MEDI-353) to Reduce Oral Corticosteroid Use in Patients with Uncontrolled Asthma on High Dose Inhaled Corticosteroid plus Long-

  Calhoun, W.

  7/15/14 → 7/14/16

  Project: Other project

• A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-Controlled,Phase 3 Efficacy and Safety Study of Benralizumab (MEDI-353) to Reduce Oral Corticosteroid Use in Patients with Uncontrolled Asthma on High Dose Inhaled Corticosteroid plus Long-

  Calhoun, W.

  AstraZeneca LP

  7/15/14 → 12/31/16

  Project: Other project

• A multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction e 40% (L

  Khalife, W.

  1/21/21 → 1/20/26

  Project: Other project

• A multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction e 40% (L

  Khalife, W.

  Bayer HealthCare Pharmaceuticals

  1/21/21 → 1/20/26

  Project: Other project

• A Multicenter, Randomized, Double-blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients

  Chatila, K.

  9/1/13 → 6/30/18

  Project: Other project

• A Multicenter, Randomized, Double-blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients

  Chatila, K.

  8/12/16 → 6/30/17

  Project: Other project

• A Multicenter, Randomized, Double-blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients

  Chatila, K.

  Novartis Pharmaceuticals Corporation

  9/1/13 → 6/30/18

  Project: Other project

• A Multicenter, Randomized Controlled Trial, Prospectively Evaluating the Clinical Utility of the Nodify XL2 Proteomic Classifier in Incidentally Discovered Low to Moderate Risk Lung Nodules

  Nishi, S.

  Biodesix

  6/2/20 → 6/1/22

  Project: Other project

• A Multicenter, Randomized Controlled Trial, Prospectively Evaluating the Clinical Utility of the Nodify XL2 Proteomic Classifier in Incidentally Discovered Low to Moderate Risk Lung Nodules

  Nishi, S.

  Biodesix

  6/2/20 → 6/1/22

  Project: Other project

• A Multicenter, Randomized Controlled Trial, Prospectively Evaluating the Clinical Utility of the Nodify XL2 Proteomic Classifier in Incidentally Discovered Low to Moderate Risk Lung Nodules

  Nishi, S.

  6/2/20 → 6/1/23

  Project: Other project

• A Multicentre, Randomized, Double-blind, Parallel Group, Placebocontrolled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting ß2 Agonist in Patients with Uncontrolled Asthma (SIRO

  Calhoun, W.

  AstraZeneca LP

  6/18/14 → 6/17/16

  Project: Other project

• A Multicentre, Randomized, Double-blind, Parallel Group, Placebocontrolled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting ß2 Agonist in Patients with Uncontrolled Asthma (SIRO

  Calhoun, W.

  6/18/14 → 6/17/16

  Project: Other project

• A Multicentre, Randomized, Double-blind, Parallel Group, Placebocontrolled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting ß2 Agonist in Patients with Uncontrolled Asthma (SIRO

  Calhoun, W.

  6/18/14 → 6/17/16

  Project: Other project

• A Multi-Omics Approach to Identify a Biomarker Panel for the Early Detection of Hepatocellular Carcinoma in Hepatitis C + Individuals

  Spratt, H.

  9/13/16 → 8/31/17

  Project: Other project

• A Multi-Omics Approach to Identify a Biomarker Panel for the Early Detection of Hepatocellular Carcinoma in Hepatitis C + Individuals

  Spratt, H.

  9/13/16 → 8/31/18

  Project: Other project

• A Multi-Omics Approach to Identify a Biomarker Panel for the Early Detection of Hepatocellular Carcinoma in Hepatitis C + Individuals

  Spratt, H.

  9/13/16 → 8/31/18

  Project: Other project

• A Multi-Omics Approach to Identify a Biomarker Panel for the Early Detection of Hepatocellular Carcinoma in Hepatitis C + Individuals

  Spratt, H.

  National Cancer Institute

  9/13/16 → 8/31/18

  Project: Other project

• A Multiomics Approach towards Deciphering the Influence of the Microbiome on Preterm Birth.

  Menon, R.

  9/27/13 → 6/30/18

  Project: Other project

• A Multiomics Approach towards Deciphering the Influence of the Microbiome on Preterm Birth.

  Menon, R.

  9/27/13 → 6/30/18

  Project: Other project

• A Multi-Site Clinical Evaluation of the ARIES Flu A/B & RSV+SARS-CoV-2 Assay in Symptomatic Patients

  Ren, P.

  Luminex Corporation

  1/1/00 → 1/1/00

  Project: Other project

• A Multi-Site Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (RPP) in Symptomatic Patients

  Ren, P.

  Luminex Corporation

  1/15/21 → 1/15/22

  Project: Other project

• A Multi-Site Clinical Evaluation of the VERIGENE II Respiratory (RP) Assay in Symptomatic Patients

  Ren, P.

  10/1/18 → 6/15/19

  Project: Other project

• A Multi-Site Clinical Evaluation of the VERIGENE II Respiratory (RP) Assay in Symptomatic Patients

  Ren, P.

  Luminex Corporation

  10/1/18 → 6/15/19

  Project: Other project

• Amygdala Serotonin Neurotransmission and Neuropathic Pain

  Green, T.

  Texas Tech University Health Sciences Ct

  7/1/14 → 2/28/18

  Project: Other project

• Amygdala Serotonin Neurotransmission and Neuropathic Pain

  Green, T.

  7/1/14 → 2/28/18

  Project: Other project

• Analysis of a focused set of compounds, blinded to name and structure, from Sponsor's internal compound collection for in vitro antiviral activity in UTMB's assay against SARS-CoV2/COVID-19

  Shi, P.

  Merck Sharp & Dohme Corporation

  6/11/20 → 12/31/21

  Project: Other project

• Analysis of a focused set of compounds, blinded to name and structure, from Sponsor's internal compound collection for in vitro antiviral activity in UTMB's assay against SARS-CoV2/COVID-19

  Shi, P.

  Merck Sharp & Dohme Corporation

  6/11/20 → 12/31/21

  Project: Other project

• Analysis of a focused set of compounds, blinded to name and structure, from Sponsor's internal compound collection for in vitro antiviral activity in UTMB's assay against SARS-CoV2/COVID-19

  Shi, P.

  6/11/20 → 12/31/22

  Project: Other project

• Analysis of a novel Crimean-Congo hemorrhagic fever vaccine and its mechanism of protection in rodent models

  Bente, D.

  1/1/00 → 1/1/00

  Project: Other project

• Analysis of Coronavris-Host Cell Interactions

  Makino, S.

  National Inst of Allergy & Infectious Di

  3/15/12 → 2/28/18

  Project: Other project

• Analysis of IL28B Polymorphisms Relationship with Spontaneous Clearance of HDV Infection in Mongolian Population

  Enkhbaatar, P.

  6/29/18 → 6/28/19

  Project: Other project

• Analysis of IL28B Polymorphisms Relationship with Spontaneous Clearance of HDV Infection in Mongolian Population

  Enkhbaatar, P.

  6/29/18 → 6/28/19

  Project: Other project

• Analysis of intrahepatic macrophage profiles for predicting risk of fibrosis development in patients with different types of chronic liver disease

  Stevenson-Lerner, H.

  National Inst of Diabetes & Digestive &

  4/1/21 → 3/31/26

  Project: Other project

• ANALYSIS OF INTRAHEPATIC MACROPHAGE PROFILES FOR PREDICTING RISK OF FIBROSIS DEVELOPMENT IN PATIENTS WITH DIFFERENT TYPES OF CHRONIC LIVER DISEASE

  Stevenson-Lerner, H.

  Moody Endowment, The

  8/13/20 → 8/12/22

  Project: Other project

• Analytical Performance Evaluation of the ACCU-Check Inform ll system in Critically lll Neonatal and Pediatric Patients/CIM RD002446

  Okorodudu, A.

  8/6/15 → 8/7/17

  Project: Other project

• Analytical Performance Evaluation of the ACCU-Check Inform ll system in Critically lll Neonatal and Pediatric Patients/CIM RD002446

  Okorodudu, A.

  Roche Diagnostics

  8/6/15 → 8/7/17

  Project: Other project

• A Natural History Study of Acute Hepatic Porphyria (AHP) Patients with Recurrent Attacks ALN-AS1-NT-001

  Anderson, K.

  Alnylam Pharmaceuticals, Inc

  8/14/14 → 12/31/23

  Project: Other project

• A Natural History Study of Acute Hepatic Porphyria (AHP) Patients with Recurrent Attacks ALN-AS1-NT-001

  Anderson, K.

  8/14/14 → 2/10/21

  Project: Other project

• A Natural History Study of Acute Hepatic Porphyria (AHP) Patients with Recurrent Attacks ALN-AS1-NT-001

  Anderson, K.

  8/14/14 → 12/31/23

  Project: Other project

• Andrea DeMaria

  Berenson, A.

  2/1/11 → 4/30/11

  Project: Other project

• Andrea DeMaria

  Berenson, A.

  2/1/11 → 4/30/11

  Project: Other project

• An Expanded Access Treatment Protocol for Zmapp TM for Patients with Ebola Virus Disease (EVD) or Ebola Virus Exposure

  Rupp, R.

  5/1/18 → 6/26/19

  Project: Other project

• An Expanded Access Treatment Protocol for Zmapp TM for Patients with Ebola Virus Disease (EVD) or Ebola Virus Exposure

  Rupp, R.

  5/1/18 → 6/26/19

  Project: Other project

• An Expanded Access Treatment Protocol for Zmapp TM for Patients with Ebola Virus Disease (EVD) or Ebola Virus Exposure

  Rupp, R.

  ICON Government & Public Health Solution

  5/1/18 → 6/26/19

  Project: Other project